| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |